Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer

ClinicalTrials.gov ID: NCT02664077

Public ClinicalTrials.gov record NCT02664077. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer

Study identification

NCT ID
NCT02664077
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
NSABP Foundation Inc
Network
Enrollment
34 participants

Conditions and interventions

Interventions

  • Regorafenib Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2016
Primary completion
Sep 30, 2019
Completion
Sep 30, 2019
Last update posted
Apr 13, 2022

2016 – 2019

United States locations

U.S. sites
51
U.S. states
26
U.S. cities
50
Facility City State ZIP Site status
St. Joseph Hospital of Orange Orange California 92868
St. Joseph Heritage Healthcare Santa Rosa California 95403
Kaiser Permanente Medical Center - Vallejo Vallejo California 94589
Colorado Cancer Research Program Denver Colorado 80222
Yale University New Haven Connecticut 06510
University of Florida Gainesville Florida 32610
Mount Sinai Comprehensive Cancer Center Miami Beach Florida 33140
Memorial Health University Medical Center Savannah Georgia 31404
Cancer Care Specialists of Illinois - Decatur Memorial Hospital Decatur Illinois 62526
Edward Hospital Cancer Center Naperville Illinois 60540-7499
Carle Cancer Center Urbana Illinois 61801
Northern Indiana Cancer Research Consortium South Bend Indiana 46628
Oncology Associates at Mercy Medical Center Cedar Rapids Iowa 52403
Genesis Medical Center - West Campus Davenport Iowa 52804
University of Iowa Iowa City Iowa 52242
Covenant Cancer Treatment Center Waterloo Iowa 50702
Norton Cancer Institute, Norton Healthcare Pavilion Louisville Kentucky 40202
Tulane University Health Sciences Center New Orleans Louisiana 70112
New England Cancer Specialists Scarborough Maine 04074
Berkshire Medical Center Cancer and Infusion Center Pittsfield Massachusetts 01201
Breslin Cancer Center Lansing Michigan 48910
Metro Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota 55416
Missouri Valley Cancer Consortium Omaha Nebraska 68106
Nevada Cancer Research Foundation, Inc. Las Vegas Nevada 89106
MD Anderson Cancer Center at Cooper Camden New Jersey 08103
Monmouth Medical Center Long Branch New Jersey 07740-6395
Newark Beth Israel Medical Center Newark New Jersey 07112
Community Medical Center Toms River New Jersey 08755
Waverly Hematology Oncology Cary North Carolina 27511
CaroMont Regional Medical Center Gastonia North Carolina 28054
Margaret R. Pardee Memorial Hospital Hendersonville North Carolina 28791
First Health of the Carolinas Cancer Center Pinehurst North Carolina 28374
Wake Forest Baptist Health Winston-Salem North Carolina 27157
James Cancer Hospital and Solove Research Institute at the Ohio State University Comprehensive Cancer Center Columbus Ohio 43210
Toledo Clinic Cancer Center Toledo Ohio 43623
Abington Hospital -Jefferson South Abington Pennsylvania 19001
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
Allegheny General Hospital Pittsburgh Pennsylvania 15212
UPMC Cancer Centers Pittsburgh Pennsylvania 15232
Guthrie Medical Group, PC Sayre Pennsylvania 18840
Scranton Hematology Oncology Scranton Pennsylvania 18510
Reading Hospital - McGlinn Cancer Institute West Reading Pennsylvania 19611
AnMed Health Cancer Center Anderson South Carolina 29621
McLeod Cancer Center for Treatment and Research Florence South Carolina 29502
Wellmont Medical Associates Oncology and Hematology Kingsport Tennessee 37660
Thompson Cancer Survival Center Knoxville Tennessee 37916
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410
Virginia Commonwealth University Richmond Virginia 23298
West Virginia University Morgantown West Virginia 26506
Green Bay Oncology, Ltd. - St. Vincent Hospital Green Bay Wisconsin 54301

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02664077, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02664077 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →